Migraine and patent foramen ovale

Current Neurology and Neuroscience Reports

Volumn 14, Issue 2, 2014, Pages

  Ailani, Jessica ^a  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

Migraine; Migraine with aura; Patent foramen ovale; Patent foramen ovale closure; Right to left shunt; Visual aura

Indexed keywords

ATRIAL SEPTAL OCCLUDER; CAUSAL ATTRIBUTION; CLINICAL EFFECTIVENESS; DISEASE ASSOCIATION; DISEASE SEVERITY; HEART SURGERY; HIGH RISK POPULATION; HUMAN; MIGRAINE; MIGRAINE WITH AURA; PATENT FORAMEN OVALE; QUALITY OF LIFE; REVIEW; SELF REPORT; TREATMENT OUTCOME; VALSALVA MANEUVER;

FORAMEN OVALE, PATENT; HUMANS; MIGRAINE DISORDERS; MIGRAINE WITH AURA;

EID: 84891650445     PISSN: 15284042     EISSN: 15346293     Source Type: Journal    
DOI: 10.1007/s11910-013-0426-4     Document Type: Review

References (46)

1. Lipton RB, Stewart WF, Diamond S, et al. Prevalence and burden of migraine in the United States; Data from the American Migraine Study II. Headache. 2001;41:646-57. (Pubitemid 32777747)
2. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders 3rd Edition (beta version). Cephalalgia. 2013;33:645-66.
3. Weber F, Goriup A. Prevalence of right to-left shunts in active fighter pilots. Aviat Space Environ Med. 2007;78:135-6. (Pubitemid 46213111)
4. • Sharma A, Gheewala N, Silver P. Role of patent foramen ovale in migraine etiology and treatment: a review. Echocardiography. 2011;28:913-7. Good review of data.
5. Schwedt TJ, Dodick DW. Patent foramen ovale and migraine-bringing closure to the subject. Headache. 2006;46:663-71.
6. Downson A, Mullen MJ, Peatfield R, et al. Migraine Intervention with STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation. 2008;117:1397-404.
7. J Interv Cardiol. 2003;16:39-42.
8. •• Schwerzmann M, Meirer B. Impact of percutaneous patent foramen ovale closure on migraine course. Interv Cardiol. 2013;5:177-87. Thorough review of data on PFO and migraine.
9. Di Tullio M, Sacco RL, Venketasubramanian N, et al. Comparison of diagnostic techniques for the detection of a patent foramen ovale in stroke patients. Stroke. 1993;24:1020-4. (Pubitemid 23201460)
10. Zito C, Dattillo G, Oreto G, et al. Patent foramen ovale: comparison among diagnostic strategies in cryptogenic stroke and migraine. Echocardiography. 2009;26:495-503.
11. Schwedt TJ, Demaerschalk BM, Dodick DW. Patent foramen ovale and migraine: a quantitative systemic review. Cephalalgia. 2008;28:531-40. (Pubitemid 351502553)
12. Garg P, Servoss SJ, Wu JC, et al. Lack of association between migraine headache and patent foramen ovale: results of a case-control study. Circulation. 2010;112:1406-12.
13. Davis D, Gregson J,Willeit P, et al. Patent foramen ovale, ischemic stroke andmigraine: systemic review and stratifiedmeta-analysis of association studies. Neuroepidemiology. 2012;40:56-67.
14. Rundek T, Elkin MS, Di TullioMR, et al. Patent foramen ovale and migraine: a cross-sectional study from the northernmanhattan study (NOMAS). Circulation. 2008;118:1419-24.
15. Wilmshurst P, Nightingale S. Relationship between migraine and cardiac and pulmonary right-to-left shunts. Clin Sci. 2001;100:215-20. (Pubitemid 32165366)
16. Wilmshurst P, Pearson M, Nightingale S. Re-evaluation of the relationship between migraine and persistent foramen ovale and other right-to-left shunts. Clin Sci. 2005;108:365-7. (Pubitemid 40517000)
17. Schwerzmann M, Nedeltchev K, Lagger F, et al. Prevalence and size of directly detected patent foramen ovale inmigraine with aura. Neurology. 2005;65:1415-8. (Pubitemid 41552772)
18. Anzola GP, Morandi E, Casilli F, Onorato E. Different degrees of right-to-left shunting predict migraine and stroke: data from 420 patients. Neurology. 2006;66:765-7. (Pubitemid 43739842)
19. Jesurum JT, Fuller CJ, Velez CA, et al. Migraineurs with patent foramen ovale have a larger right-to-left shunt on transcranial Doppler: a case control study. J Headache Pain. 2007;8:209-16. (Pubitemid 350020773)
20. • van Gent MWF, Mager JJ, Snijder RJ, et al. Relation between migraine and size of echocardiographic intrapulmonary right-to-left shunt. J Cardiol. 2011;107:1399-404. Interesting study of migraine and shunt size.
21. • Chambers J, Seed PT, Ridsdale L. Association of migraine aura with patent foramen ovale and atrial septal aneurysms. Int J Cardiol. 2013;168:3949 - 53. Sites incidence of PFO in patients with migraine.
22. • McCandless RT, Arrington CB, Nielsen DC, et al. Patent foramen ovale in children with migraine headaches. J Pediatr. 2011;159:243-7. Only article looking at PFO in children with migraine.
23. Zeller JA, Frahm K, Baron R, et al. Platelet-leukocyte interaction and platelet activation in migraine: a link to ischemic stroke? J Neurol Neurosurg Psychiatry. 2004;75:984-7. (Pubitemid 38869610)
24. Giardini A, Donti A, Formigari R, et al. Transcatheter patent foramen ovale closure mitigates aura migraine headaches abolishing spontaneous right-to-left shunting. Am Heart J. 2006;151:922.e1-5.
25. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. Heart. 2005;91:1173-5. (Pubitemid 41192391)
26. Kaaro J, Partonen, Naik P, et al. Is migraine a lateralization defect? Neuroreport. 2008;19:1351-3.
27. Anzola GP, Frisoni GB, Morandi E, et al. Shunt-associated migraine responds favorably to atrial septal repair. A case-control study. Stroke. 2006;37:430-4. (Pubitemid 43732000)
28. Morandi E, Anzola GP, Angeli S, et al. Transcatheter closure of patent foramen ovale: a new migraine treatment? J Interv Cardiol. 2003;16:39-42. (Pubitemid 36293092)
29. Jesurum JT, Fuller CJ, Kim CJ, et al. Frequency of migraine headache relief following patent foramen ovale "closure" despite residual right-to-left shunt. Am J Cardiol. 2008;102:916-20.
30. Lutermans J, Post MC, Temmerman F, et al. Closure of patent foramen ovale is associated with a decrease in prevalence of migraine: a prospective observational study. Acta Cardiol. 2008;63:571-7.
31. Schwerzmann M, Wiher S, Nedeltchev K, et al. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology. 2004;62:1399-401. (Pubitemid 38526056)
32. Post MC, Thijs V, Herroelen L, et al. Closure of patent foramen ovale is associated with a decrease in prevalence of migraine. Neurology. 2004;62:1439-40. (Pubitemid 38526070)
33. ReismanM, Chistofferson RD, Jesurum J, et al. Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol. 2005;45:493-5. (Pubitemid 40222239)
34. Slavin L, Tobis JM, Rangarajan K, et al. Five-year experience with percutaneous closure of patent foramen ovale. Am J Cardiol. 2007;99:1316-20. (Pubitemid 46659873)
35. DubielM, Brush L, Schmehl I, et al.Migraine headache relief after percutaneous transcatheter closure of interatrial communications. J Interv Cardiol. 2008;21:32-7. (Pubitemid 351178399)
36. Wilmshurst PT, Nightingale S, Walsh KP, et al. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet. 2000;356:1648-51.
37. Azarbal B, Tobis J, Suh W, et al. Association of interatrial shunts and migraine headaches: impact of transcatheter closure. J Am Coll Cardiol. 2005;4:489-92. (Pubitemid 40222238)
38. •• Butera G, Biondi-Zoccai GG, Carminati M, et al. Systemic review and meta-analysis of currently available clinical evidence on migraine and patent foramen ovale percutaneous closure: much ado about nothing? Catheter Cardiovasc Interv. 2010;75:494-504. Only meta-analysis of PFO closure trials.
39. Rigatelli G, Dell'Avvocata F, Ronco F, et al. Primary transcatheter patent foramen ovale closure is effective in improving migraine in patients with high-risk anatomic and functional characteristics for paradoxical embolism. JACC Cardiovasc Interv. 2010;3:282-7.
40. Rigatelli G, Dell'Avvocata F, Cardaioli P, et al. Improving migraine by means of primary transcatheter patent foramen ovale closure: long-term follow up. Am J Cardiovasc Dis. 2012;2:89-95.
41. Trabattoni D, Fabbiocchi F, Montosrsi P, et al. Sustained long-term benefit of patent foramen ovale closure on migraine. Catheter Cardiovasc Interv. 2011;77:570-4. Accessed 24 Dec 2013.
42. Khessali H, Mojadidi MK, Gevorgyan R, et al. The effect of patent foramen ovale closure on visual aurawithout headache or typical aura with migraine headache. JACC Cardiovasc Interv. 2012;5:682-7.
43. PREMIUM. http://clinicaltrials.gov/ct2/show/NCT00355056. Accessed 24 Dec 2013.
44. PRIMA. http://www.clinicaltrials.gov/ct2/show/NCT00505570. Accessed 24 Dec 2013.
45. MIST II. http://www.clinicaltrials.gov/ct2/show/NCT00283738. Accessed 24 Dec 2013.
46. ESCAPE. http://www.clinicaltrials.gov/ct2/show/NCT0267371. Accessed 24 Dec 2013.